Max Chat
Share chart PerkinElmer
Extended chart
Simple chart
About PerkinElmer
PerkinElmer, Inc., американская глобальная корпорация, специализирующаяся в областях диагностики, исследований в области биологических наук, пищевых продуктов, экологических и промышленных испытаний. Его возможности включают в себя обнаружение, визуализацию, информатику и обслуживание.Main settings
IPO date
1983-04-06
ISIN
US7140461093
Industry
Life Sciences Tools & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0.2101
Дивиденд ао
0.07
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 5.37 | 2 |
| P/BV | 2.4 | 6 |
| P/E | 30.7 | 5 |
Efficiency
| Title | Value | Grade |
| ROA | 3.97 | 1 |
| ROE | 7.98 | 2 |
| ROIC | 8.67 | 3 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0.7857 | 7.86 |
| Average dividend growth | -25 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 3.8 | 3 |
| Debt/Ratio | 0.3227 | 10 |
| Debt/Equity | 0.9095 | 9 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 16.67 | 3 |
| Yield Ebitda, % | 77.83 | 8 |
| Yield EPS, % | 53.92 | 7 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 111.09 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 111.09 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Month | 111.09 $ | 111.09 $ | 111.09 $ | 0 % | 0 % | 0 % |
| Three month | 111.09 $ | 111.09 $ | 111.09 $ | 0 % | 0 % | 0 % |
| Half a year | 111.09 $ | 111.09 $ | 111.09 $ | 0 % | 0 % | 0 % |
| Year | 111.09 $ | 111.09 $ | 111.09 $ | 0 % | 0 % | 0 % |
| 3 years | 129.92 $ | 111.09 $ | 162.76 $ | -14.49 % | 0 % | 0 % |
| 5 years | 139.79 $ | 99.57 $ | 201.93 $ | -20.53 % | 0 % | 0 % |
| 10 years | 55.14 $ | 42.47 $ | 201.93 $ | 101.47 % | 0 % | 0 % |
| Year to date | 111.09 $ | 111.09 $ | 111.09 $ | 0 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| MicroSectors Cannabis 2X Leveraged ETN | 7.03 | 88.65 | 0.95 |
| AdvisorShares Vice ETF | 4.97 | 13.69 | 0.99 |
| Pacer BioThreat Strategy ETF | 0.5194 | 9.1 | 0.7 |
| IQ 500 International ETF | 0.14586 | 3.01 | 0.25 |
| Columbia U.S. ESG Equity Income ETF | 0.02745 | 0.5223 | 0.35 |
| JPMorgan U.S. Aggregate Bond ETF | 0.02 | 2.54 | 0.07 |
| 2.12 | 19.59 | 0.55 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Prahlad R. Singh Ph.D. | CEO, Pres & Director | 3.23M | 1965 (60 years) |
| Mr. Tajinder Vohra | Sr. VP of Global Operations | 927.24k | 1966 (59 years) |
| Mr. Joel S. Goldberg | Sr. VP of Admin., Gen. Counsel & Sec. | 1.29M | 1969 (56 years) |
| Mr. Daniel R. Tereau | Sr. VP of Strategy & Bus. Devel. | 967.97k | 1968 (57 years) |
| Mr. Andrew Okun | VP, Chief Accounting Officer & Treasurer | N/A | 1970 (55 years) |
| Mr. Robert Francis Friel | Advisor | N/A | 1956 (69 years) |
| Ms. Miriame Victor | Sr. VP & Chief Commercial Officer | N/A | 1981 (44 years) |
| Mr. Stephen Barr Willoughby | Sr. VP of Investor Relations & Head of ESG | N/A | |
| Dr. Masoud Toloue Ph.D. | Sr. VP of Diagnostics | N/A | 1980 (45 years) |
| Mr. Maxwell Krakowiak | Sr. VP & CFO | 814.58k | 1989 (36 years) |
About company
Address: United States, Waltham, 940 Winter Street - Open in google maps, Open in yandex maps
Website: http://www.perkinelmer.com
Website: http://www.perkinelmer.com
